Letter Sequence Meeting |
|---|
EPID:L-2020-NEW-0003, Daher Nuclear Technologies Gmbh Submittal of Proprietary Application for the DN30-X Package (Approved, Closed) |
Results
Other: ML21049A334, ML21259A218, ML21281A049, ML22252A038, ML22252A039, ML22327A181, ML22327A183, ML23045A114, ML23083B978, ML23083B979, ML25085A157, ML25085A158, ML25085A159, ML25085A160, ML25119A147, ML25119A148, ML25119A154, ML25119A155, ML25119A156, ML25119A157, ML25191A058, ML25191A059, ML25191A060, ML25191A061
|
MONTHYEARML21012A1942021-01-12012 January 2021 Notice of Pre-Application Meeting with Daher for the Model No. DN30-X Package Project stage: Meeting ML21049A3342021-02-17017 February 2021 Enclosure 2: Slide Presentation-NRC-Preapplication-17-02-2021 Public Project stage: Other ML21049A3332021-02-22022 February 2021 Memorandum: C. Regan-Meeting Summary February 2021 Project stage: Meeting ML21181A0012021-06-29029 June 2021 Daher Nuclear Technologies Gmbh Submittal of Proprietary Application for the DN30-X Package Project stage: Request ML21181A0002021-06-29029 June 2021 Daher Nuclear Technologies Gmbh Submittal of Proprietary Application for the DN30-X Package Project stage: Request ML21281A0462021-08-10010 August 2021, 6 October 2021, 8 October 2021 Orano NCS Gmbh - Answers to Rsis for the Review of the DN30-X Package Project stage: Request ML21259A2182021-09-22022 September 2021 Request for Supplemental Information Project stage: Other ML21259A2162021-09-22022 September 2021 Request for Supplemental Information for the Review of the Model No. DN30-X Project stage: Request ML21259A2172021-09-22022 September 2021 Request for Supplemental Information for the Review of the DN30-X Project stage: Approval ML21281A0492021-10-0606 October 2021 0045-BSH-2020-001, Rev. 1, Safety Analysis Report for the DN30-X Package Project stage: Other ML21291A0642021-10-19019 October 2021 Application for the Model No. DN-30X- Acceptance Letter Project stage: Acceptance Review ML22252A0392022-05-0909 May 2022 0045-BSH-2020-001-Appendix 1.7.3, Rev. 0 - Facility Operations with the 30B-X Cylinder Project stage: Other ML22252A0382022-09-0909 September 2022 0045-BSH-2020-001, Rev. 2 - Safety Analysis Report for the DN30-X Package Project stage: Other ML22327A1802022-11-23023 November 2022 Submittal of DN30-X Package: Modification of CCS Orientation Inside 30B-X Cylinder Project stage: Request ML22327A1832022-11-23023 November 2022 Safety Analysis Report for the DN30-X Package 0045-BSH-2020-001, Rev. 3 Project stage: Other ML22327A1812022-11-23023 November 2022 Submittal of DN30-X Package: Modification of CCS Orientation Inside 30B-X Cylinder Project stage: Other ML23045A1142023-02-0909 February 2023 Submittal of DN30-X Package: Exchange of Two Pages in Appendix 2.2 of the SAR Project stage: Other ML23083B9772023-03-27027 March 2023 Certificate of Compliance No. 9388, Revision No. 0, for the Model No. DN30-X Package Project stage: Request ML23083B9782023-03-27027 March 2023 Certificate of Compliance No. 9388, Revision No. 0 Project stage: Other ML23083B9792023-03-27027 March 2023 Cover Letter: Certificate of Compliance No. 9388, Rev. No. 0, for the Model No. DN30-X Package Project stage: Other ML23083B9802023-03-27027 March 2023 Safety Evaluation Report for Revision No. 0 of the Certificate of Compliance No. 9388 Project stage: Approval ML25085A1602025-03-25025 March 2025 Orano - Periodic Inspections of 30B-X Cylinders Project stage: Other ML25085A1592025-03-25025 March 2025 Orano - Contamination and Dose Rate Measurements at the DN30-X Package Project stage: Other ML25119A1482025-03-25025 March 2025 Orano NCS Gmbh - Affidavit Project stage: Other ML25119A1472025-03-25025 March 2025 Orano NCS Gmbh - Renewal of the DN30-X CoC Docket No. 71-9388; EPID No. L-2020-NEW-0003 Project stage: Other ML25119A1562025-03-25025 March 2025 Orano NCS Gmbh - 0045-BSH-2020-001-Appendix-1.7.3. Rev. 2, Facility Operations with 30B-X Cylinders Project stage: Other ML25085A1572025-03-25025 March 2025 Orano - Safety Analysis Report for the DN30-X- Package Project stage: Other ML25085A1582025-03-25025 March 2025 Orano - Use and Handling of the DN30-X Package Project stage: Other ML25119A1542025-03-25025 March 2025 Orano NCS Gmbh - 0045-HA-2021-001, Rev. 2, Handling Instruction: Use and Handling of the DN30-X Package Project stage: Other ML25119A1572025-03-25025 March 2025 Orano NCS Gmbh - 0045-PA-2021-001, Rev. 1, Test Instruction: Periodic Inspections of 30B-X Cylinders Project stage: Other ML25119A1552025-03-25025 March 2025 Orano NCS Gmbh - 0045-PA-2021-002, Rev. 1, Test Instruction: Contamination and Dose Rate Measurements at the DN30-X Package Project stage: Other ML25085A1562025-03-25025 March 2025 Public Application for Renewal of the DN30-X- CoC Project stage: Request ML25191A0612025-07-10010 July 2025 Orano NCS Gmbh - Test Instruction, Periodic Inspections of 30B-X Cylinders 0045-PA-2021-001-Rev1 Project stage: Other ML25191A0592025-07-10010 July 2025 Orano NCS Gmbh - Test Instruction, Contamination and Dose Rate Measurements at the DN30-X Package, 0045-PA-2021-002 Rev. 1 Project stage: Other ML25191A0602025-07-10010 July 2025 Orano NCS Gmbh - Facility Operations with 30B-X Cylinders 0045-BSH-2020-001-Appendix 1.7.3, Rev. 2 Project stage: Other ML25191A0582025-07-10010 July 2025 Orano NCS Gmbh - Handling Instruction - Use and Handling of the DN30-X Package Project stage: Other ML25191A0562025-07-10010 July 2025 Orano NCS Gmbh - Public Application for Renewal of the DN30-X CoC Project stage: Request 2021-09-22
[Table View] |
Text
C. Regan UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 February 22, 2021 MEMORANDUM TO:
Christopher Regan, Deputy Director Division of Fuel Management, NMSS FROM:
Pierre Saverot, Project Manager R/A Storage and Transportation Licensing Branch Division of Fuel Management, NMSS
SUBJECT:
SUMMARY
OF FEBRUARY 17, 2021 MEETING WITH DAHER NUCLEAR TECHNOLOGIES
=
Background===
On February 17, 2021, a Category 1 public meeting was held by video conference between the U.S. Nuclear Regulatory Commission (NRC) staff and representatives from Daher Nuclear Technologies GmbH (DNT) to discuss the licensing approach for a new UF6 package design, DN30-X, for enrichments between 10% and 20%. The first pre-application meeting was held on June 10, 2020.
The February 17, 2021, meeting was noticed on January 12, 2021 (ML21012A194). The meeting attendance list and public presentation are provided as Enclosure Nos. 1 and 2, respectively.
Discussion Recent industry developments such as initiatives for Accident Tolerant Fuel, DOE-NNSA tritium production project, fuel for small modular reactors, as well as high assay low-enriched uranium projects, drive up the need for transportation of UF6 enriched above 5%, i.e., between 10% and 20%, thus the need for a new UF6 package design. The licensing approach selected by DNT consists in designing a new cylinder, the 30B-X cylinder, derived from the ANSI N14.1 30B cylinder but with added criticality control rods. The 30B-X cylinder will fit into the Protective Structural Packaging (PSP) already certified under Docket No. 71-9362. A 30B-10 cylinder (10% enrichment) holds 3527 lbs. of UF6 while a 30B-20 cylinder (20% enrichment) has a capacity of 2756 lbs. of UF6. DNT presented the results of the structural and criticality analyses (including the benchmark evaluation with the TSUNAMI code).
Staff asked if this design is meant to respond to all foreseeable industry needs, or if there may be eventually a need for other designs in future applications. DNT said that their concept, presented at the last PATRAM conference, was well received by industry, that it favors a sound transportation scheme by minimizing the number of shipments due to the high capacity of the 30B-X cylinder, and that it features the same handling needs and tools than for the existing 30B cylinder (identical dimensions and maximum gross weight, identical valve and plug, similar washing/cleaning procedures than for 30B cylinder. There was no question from the public during the public session.
Pierre M.
Saverot Digitally signed by Pierre M. Saverot Date: 2021.02.22 13:33:06 -05'00'
C. Regan The structural and criticality evaluations of the DN30-X package were discussed during the proprietary session. Staff asked a number of questions on (i) the criticality control system (CCS) restraints and their welding, (ii) their modeling and the potential for an uneven distribution of UF6 during actual loading conditions, (iii) the selection of experiments for the criticality analysis and if there had been a similar analysis performed for an unmoderated system. Staff said that part of the focus during the review of the DNT application will be on the validation of the criticality cases with similar benchmarks.
Staff made no regulatory commitment during the meeting.
Docket No. 71-9388 EPID - L-2020-NEW-0003
Enclosures:
- 1. Meeting Attendees
- 2. Presentation
C. Regan
SUBJECT:
SUMMARY
OF FEBRUARY 17, 2021 MEETING WITH DAHER NUCLEAR TECHNOLOGIES DOCUMENT DATED: FEBRUARY 22, 2021 DISTRIBUTION: SFST r/f, A. Kock, ADimitriadis, RI; BDesai, RII; DHills, RIII; GWarnick, RIV G:\\SFST\\Saverot\\71-9388 DN30-X\\meeting summaryFebruary 2021.doc ADAMS Package No.: ML21049A332
SFM C
SFM NAME
- SFigueroa JMcKirgan DATE 02/18/2021 02/18/2021 02/22/2021 OFFICIAL RECORD COPY
Meeting Between DAHER NUCLEAR TECHNOLOGIES (DNT) and the Nuclear Regulatory Commission February 17, 2021 Meeting Attendees NRC/NMSS/DSFM Pierre Saverot Andrew Barto Jonathan Marcano John McKirgan Marilyn Diaz Tom Boyce Bernard White DNT Yara van Wijk Maik Hennebach Franz Hilbert Sebastian Fels DOT Richard Boyle Mike Conroy URENCO Wyatt Patchett Joel Kruehler PUBLIC Benjamin Holtzman (NEI)
Lance Sterling (Certrec Corporation)